CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $414,640 | -12.9% | 71,000 | 0.0% | 0.15% | -21.9% |
| Q3 2022 | $476,000 | +64.1% | 71,000 | +2.9% | 0.19% | +68.4% |
| Q2 2022 | $290,000 | +87.1% | 69,000 | +50.0% | 0.11% | +132.7% |
| Q1 2022 | $155,000 | +6.9% | 46,000 | 0.0% | 0.05% | 0.0% |
| Q4 2021 | $145,000 | -3.3% | 46,000 | 0.0% | 0.05% | -31.9% |
| Q3 2021 | $150,000 | +2.7% | 46,000 | +33.3% | 0.07% | +26.3% |
| Q2 2021 | $146,000 | – | 34,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |